Related Experiment Video
Updated: Jan 4, 2026

Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
M0CRPC overview of management options
Y Hess-Busch1, B Hadaschik2, J Hess3
1Department of Medical Oncology, Kliniken Essen Mitte, Essen, Germany.
New treatments significantly improve metastasis-free survival for men with non-metastatic castration-resistant prostate cancer (M0CRPC). Clinicians should consider drug safety and overall survival data when choosing therapies for M0CRPC patients.
Area of Science:
- Oncology
- Urology
- Medical Research
Background:
- Prostate cancer often becomes resistant to androgen deprivation therapy (ADT), leading to castration-resistant prostate cancer (CRPC).
- The androgen receptor (AR) pathway is frequently activated in CRPC, making it a key therapeutic target.
- M0CRPC describes castration resistance without detectable metastases on conventional imaging, an area lacking a standard treatment until recently.
Purpose of the Study:
- To evaluate the efficacy of novel therapeutic agents in patients with M0CRPC.
- To compare the outcomes of recent large-scale clinical trials for M0CRPC.
Main Methods:
- Analysis of three large, placebo-controlled Phase III trials (PROSPER, SPARTAN, ARAMIS).
- Focus on patients with M0CRPC and a short PSA doubling time (PSADT).
- Assessment of metastasis-free survival as a primary endpoint.
Main Results:
- All three trials demonstrated a significant benefit in metastasis-free survival for patients treated with novel agents compared to placebo.
- Efficacy data across the studies were notably similar.
- The studies provide crucial data on the safety profiles and overall survival analyses of these new treatments.
Conclusions:
- Novel therapies offer a significant improvement in metastasis-free survival for men with M0CRPC and short PSADT.
- Drug safety, overall survival data, and drug availability are key factors for clinical decision-making in M0CRPC.
- These findings establish new therapeutic standards for M0CRPC patients.
Related Concept Videos
Methods of Documentation II: POMR
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Acute Coronary Syndrome IV: Interprofessional Care

